ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $201,000 | +8.6% | 12,221 | 0.0% | 0.04% | -8.7% |
| Q2 2016 | $185,000 | +4.5% | 12,221 | 0.0% | 0.05% | -16.4% |
| Q1 2016 | $177,000 | -61.6% | 12,221 | -25.0% | 0.06% | -54.9% |
| Q4 2015 | $461,000 | +68.9% | 16,294 | 0.0% | 0.12% | +67.1% |
| Q3 2015 | $273,000 | -36.1% | 16,294 | 0.0% | 0.07% | -8.8% |
| Q2 2015 | $427,000 | +49.8% | 16,294 | 0.0% | 0.08% | +60.0% |
| Q1 2015 | $285,000 | – | 16,294 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |